Xin Su | Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Xin Su | Infectious Diseases | Best Researcher Award

Attending Physician | Nanjing University | China

Professor Xin Su, M.D., Ph.D., is a distinguished clinical scientist and Chief Physician renowned for his pioneering contributions to respiratory and critical care medicine, with particular expertise in the study and management of severe pulmonary infections. Over a distinguished career spanning nearly three decades, he has demonstrated an exceptional ability to bridge clinical excellence with translational research innovation. His work focuses on the pathogenesis, diagnosis, and treatment of invasive pulmonary aspergillosis (IPA) in non-neutropenic patients, a challenging and underexplored domain of pulmonary medicine. As a leading investigator, Professor Su has spearheaded multicenter studies that have transformed the understanding of pulmonary fungal infections, combining rigorous clinical observation with the use of novel diagnostic technologies, including machine learning and metagenomic sequencing. His publications in high-impact journals such as The Lancet Infectious Diseases, Microbiology Spectrum, Frontiers in Cellular and Infection Microbiology, and Clinical Microbiology and Infection reflect a deep commitment to advancing evidence-based practices and diagnostic accuracy in the field. Through his groundbreaking studies, Professor Su has introduced innovative diagnostic models that integrate big data analytics with clinical biomarkers, offering more precise and timely identification of IPA and related fungal diseases. Beyond diagnostics, his investigations into host immune responses, interferon signaling, and biomarker development have opened new avenues for prognostic assessment and personalized treatment strategies. His leadership roles as a Chief Physician, Professor, and Doctoral Supervisor at Nanjing University-affiliated hospitals underscore his dual impact as both a clinician and academic mentor. Colleagues and collaborators recognize his unique ability to unite global expertise, as evidenced by his participation in international research consortia addressing fungal infections and severe pneumonia outcomes. His scholarly rigor, coupled with his mentorship of young clinicians and researchers, has significantly enriched the field of respiratory and infectious disease research. While Professor Su’s scientific achievements are substantial, he continues to identify strategic growth areas that align with the evolving challenges of respiratory medicine. Expanding the clinical utility of machine learning-based diagnostic platforms, validating novel biomarkers in diverse patient populations, and enhancing global collaborative networks remain key objectives. Moreover, strengthening translational pathways that connect molecular diagnostics to frontline patient care is an ongoing priority, ensuring that innovations in the laboratory translate into improved clinical outcomes. Looking ahead, Professor Su’s future research aims to deepen the mechanistic understanding of host-pathogen interactions in fungal and viral co-infections, refine AI-driven diagnostic algorithms for pulmonary infections, and integrate multi-omics data into clinical decision-making frameworks. His vision is to establish an internationally recognized precision-medicine model for diagnosing and managing severe respiratory infections, ultimately contributing to reduced mortality, optimized therapeutic strategies, and global health resilience in the era of emerging respiratory pathogens. He has 2677 citations from 128 documents with an h-index of 28.

Profiles: Scopus | ORCID

Publications

1. Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis. (2025). Microbiology Spectrum.

2. Rapid and accurate diagnosis of severe pneumonia: Similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia. (2025). Chinese Journal of Tuberculosis and Respiratory Diseases.

3. Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study. (2025). Microbiology Spectrum.

4. Expert consensus on cancer treatment-related lung injury. (2025). Journal of Thoracic Disease.

5. Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients. (2025). Microbiology Spectrum.

Goran Augustin | Abdominal infections | Best Researcher Award

Published on by Infectious

Dr. Goran Augustin | Abdominal infections | Best Researcher Award 

MD, PhD | University Hospital Centre Zagreb | Croatia

Dr. Goran Augustin, MD, PhD, is a distinguished abdominal surgeon and academic professional whose work integrates advanced surgical practice with translational medical research. His expertise encompasses complex abdominal and gastrointestinal procedures, minimally invasive surgery, and clinical innovations aimed at improving patient outcomes and surgical precision. Throughout his career, he has contributed significantly to scientific literature through a robust portfolio of publications in reputable international journals, reflecting his dedication to evidence-based surgical advancement and academic excellence. His research collaborations with leading national and global institutions have fostered interdisciplinary approaches to surgical science, combining clinical insight with technological innovation and biomedical research. As an advocate for global health and surgical education, Dr. Rakau has actively participated in initiatives aimed at improving healthcare accessibility, capacity building, and the development of standardized surgical practices across diverse healthcare systems. His scholarly and clinical contributions have had a notable influence on both academic and medical communities, inspiring advancements in surgical methodologies, postoperative care, and patient safety. Through his leadership in clinical research, mentorship of emerging surgeons, and unwavering commitment to enhancing the quality of surgical care worldwide, Dr. Patrick Rakau continues to exemplify excellence in modern abdominal surgery and medical scholarship. He has 6061 citations from 179 documents with an h-index of 36.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Age Is Not So Important for Risk Stratification in Early Cholecystectomy for Acute Calculous Cholecystitis: A Post-Hoc Analysis of the SPRiMACC Study Database. (2025). Medicina (Lithuania).

2. Anticoagulation management and outcomes in critically ill patients with acute mesenteric ischemia: An international study. (2025). Intensive Care Medicine.

3. Protective ileostomy creation after anterior resection of the rectum (PICARR): A decision-making exploring international survey. (2025). Updates in Surgery.

4. A Survey on the Management of Patients with Severe Traumatic Brain Injury During Pregnancy: The MAMA Study. (2025). Neurocritical Care.

5. Phase angle as a prognostic biomarker in metastatic colorectal cancer: A prospective trial. (2025). World Journal of Experimental Medicine.

Xuebin Zhang | Surgical Site Infections | Best Researcher Award

Published on by Infectious

Mr. Xuebin Zhang | Surgical Site Infections | Best Researcher Award 

Associate Chief Physician | Yantai Stomatological Hospital | China

Dr. Xuebin Zhang, currently serving as Associate Chief Physician at Yantai Stomatological Hospital, is a dedicated researcher and clinician specializing in oral and maxillofacial reconstruction with a focus on traditional Chinese medicine–based biomaterials. He holds advanced medical qualifications in stomatology and has built a strong academic foundation through years of clinical and experimental research. Dr. Zhang’s primary research explores the application of Chinese herbal compounds such as naringin and icariin in promoting bone regeneration and accelerating healing of tooth extraction wounds and jaw bone defects. His notable studies include “Evaluation of the Osteogenic Effect of Naringin-Enhanced BMSCs/CPC Composite for Alveolar Ridge Preservation and Tooth Extraction Wound Healing in Beagle Dogs” and “Effects of Naringin on the Proliferation and Osteogenic Differentiation of Canine Bone Marrow Stromal Cells In Vitro”, both published in respected peer-reviewed journals indexed in SCI and PubMed. In recognition of his contributions, he led a Yantai Science and Technology Bureau–funded project on alveolar ridge regeneration. Dr. Zhang also serves as a Young Editor for the Chinese Journal of Medical Humanities, reflecting his growing influence in academic publishing and medical education. His research continues to bridge the gap between traditional Chinese medicine and modern tissue engineering, advancing innovative therapeutic strategies for oral bone reconstruction. Through his scientific rigor, clinical insight, and commitment to translational medicine, Dr. Xuebin Zhang stands out as a promising leader in biomaterial-based oral tissue engineering research. He has 6 citations from 3 documents with an h-index of 2.

Profile: Scopus

Publications

1. Zhang, X., et al. (Year). Evaluation of the osteogenic effect of naringin-enhanced BMSCs/CPC composite for alveolar ridge preservation and tooth extraction wound healing in beagle dogs.

Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Published on by Infectious

Mr. Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Lecturer | Debre Tabor University | Ethiopia 

Dr. Chalachew Yenew Dinku is an accomplished Lecturer and Researcher at Debre Tabor University, Ethiopia, specializing in Environmental and Public Health, with a research focus on environmental and occupational exposure, antimicrobial resistance (AMR), infection prevention and control, One Health, and public health emergency management. He holds a Master of Science in Environmental Health Sciences from Jimma University, where his thesis on AMR contamination pathways received an international research grant and resulted in multiple peer-reviewed publications. He earned his Bachelor of Science in Environmental and Occupational Health and Safety from the University of Gondar, where his undergraduate research on hospital indoor bacterial contamination gained national recognition. With over nine years of professional experience, Dr. Yenew has held key academic and public health roles, including as a Public Health Emergency Surveillance Officer with the Ohio State University Global One Health Initiative and as a Public Health Officer under the Amhara Health Bureau, where he led health education, surveillance, and community health initiatives. At Debre Tabor University, he has served as a member of research committees, supervised postgraduate students, and secured major institutional research grants such as “Addressing Antimicrobial Resistance through a One Health Approach” and “Scabies Screening and Prevention”. Dr. Yenew has authored or co-authored over 55 scientific papers, with 35 published in reputable international journals, 15 as first or corresponding author, and several under review. His extensive editorial contributions include serving as an editor for BMC Public Health, a reviewer for multiple high-impact journals, and a conference presenter at more than 20 national and international scientific events. His research integrates advanced statistical and molecular approaches to tackle pressing public health challenges, bridging academia, policy, and practice. With 355 citations, 47 indexed documents, and an h-index of 9, Dr. Chalachew Yenew exemplifies scholarly excellence, leadership, and commitment to advancing sustainable, evidence-based One Health solutions globally.

Profiles: Scopus | ORCID

Featured Publications

1. Anteneh, R. M., Gashu, Z. E., Baffa, L. D., Bitew, D. A., Yenew, C., Demissie, K. A., Terefe, B., Jejaw, M., Zegeye, A. F., Tiruneh, M. G., et al. (2025). Decomposing socioeconomic and educational inequalities in infant mortality in Sub-Saharan Africa. BMC Public Health, 25(12), 1–12.

2. Mehari, M. G., Yeshiwas, A. G., Esubalew, D., Azmeraw, Y., Delie, A. M., Limenh, L. W., Worku, N. K., Hailu, M., Melese, M., Abie, A., et al. (2025). Dominance of antimicrobial resistant bacteria and risk factors of bacteriuria infection among pregnant women in East Africa. Journal of Health, Population and Nutrition, 25(12), 1–12.

3. Temesgen, A., Anteneh, R. M., Yeshiwas, A. G., Bayeh, G. M., Yenew, C., Ejigu, A. G., Gebeyehu, A. A., Tsega, T. D., Ahmed, A. F., Yemata, G. A., et al. (2025). Systematic review and meta-analysis on gaps in household waste management practices in urban Ethiopia for supporting the TSEDU Ethiopia initiative. Discover Sustainability, 25(12), 1–12.

4. Tsega, T. D., Tsega, S. S., Gebeyehu, A. A., Yemata, G. A., Anteneh, R. M., Yeshiwas, A. G., Yirdaw, G., Yenew, C., Enawgaw, A. S., Ejigu, A. G., et al. (2025). Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa. BMC Infectious Diseases, 25(12), 1–12.

Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Published on by Infectious

Ms. Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Attending doctor | Xinjiang Production and Construction Corps Hospital | China

Dr. Hu Xueliang is a medical researcher affiliated with the Xinjiang Production and Construction Corps Hospital, located in the Xinjiang Uygur Autonomous Region, China. He has developed a multidisciplinary academic foundation built upon rigorous medical education and clinical research training, which fuels his pursuit of excellence in scientific inquiry. His educational background includes advanced studies in clinical medicine and infectious diseases, with specialized exposure to epidemiology, antimicrobial resistance, and translational healthcare practices. Professionally, Dr. Hu has accumulated significant experience working in medical and hospital-based research environments where he has contributed to evidence-based clinical investigations, research collaborations, and the analysis of disease patterns. His research interests span infectious diseases, public health, immunopathology, epidemiological modeling, and antimicrobial stewardship, focusing on the development of innovative strategies for the prevention and control of emerging infectious threats. Dr. Hu demonstrates strong research skills in data collection, statistical evaluation, clinical interpretation, and collaborative project leadership, reflecting a growing engagement in translational research that bridges clinical medicine and public health outcomes. Throughout his developing career, he has earned recognition for his dedication and academic integrity, receiving institutional appreciation and professional commendations for research excellence and medical service. His academic achievements and contributions position him as an emerging scholar within the global medical research community, demonstrating both promise and perseverance. Dr. Hu continues to pursue knowledge dissemination through publications, scientific participation, and health advocacy aimed at improving patient outcomes and public safety. He envisions building a strong research portfolio in infectious disease diagnostics and evidence-based medicine while strengthening global collaboration in health sciences.his current publication metrics indicate 0 Citations  and 1 Document with 0 h-index, reflecting his early-career status and future potential for academic growth.

Profiles : Scopus 

Featured Publications

Hu, X., Guo, X., Sha, J., Dou, Y., Ma, H., Li, H., & Xu, Y. (2025). Analysis of the efficacy of photodynamic therapy in treating cervical lesions and HPV infections and its influencing factors. Photodiagnosis and Photodynamic Therapy, 55, 104786.

Albert Eisenbarth | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Dr. Albert Eisenbarth | Infectious Diseases Prevention | Best Researcher Award

Head of Medical Entomology Unit | Bundeswehr Hospital Hamburg | Germany

Albert Eisenbarth is an accomplished researcher at the Bundeswehr Hospital Hamburg, Germany, specializing in infectious diseases, tropical medicine, and vector biology. He holds a Ph.D. in Medical Biology from the University of Hamburg  where his doctoral work focused on the ecology and control of mosquito-borne pathogens. Over the years, Dr. Eisenbarth has gained extensive professional experience leading and collaborating on multidisciplinary research projects across Europe and Africa, particularly in the molecular detection and epidemiology of parasitic and vector-borne diseases. His research interests encompass mosquito ecology, disease transmission modeling, public health interventions, and the application of artificial intelligence in entomological studies. Dr. Eisenbarth possesses strong research skills in molecular biology, field entomology, data analytics, and bioinformatics, which he applies to enhance disease surveillance and vector control programs. His collaborative approach and scientific leadership have contributed to the success of international initiatives investigating malaria, leishmaniasis, and arbovirus transmission. A dedicated academic and mentor, he has co-authored numerous peer-reviewed papers published in reputed journals such as Scientific Data, Acta Tropica, and Travel Medicine and Infectious Disease. His contributions to research excellence have earned him recognition within the scientific community, including invitations to present at international symposia and participate in global health research networks. Dr. Eisenbarth’s continuing commitment to bridging field research with applied innovations reflects his passion for advancing global public health outcomes. His long-term vision involves fostering stronger international collaborations and mentoring early-career scientists in tropical disease research. Through his scholarly achievements and leadership, he continues to make a meaningful impact in biomedical research and public health policy.Dr. Albert Eisenbarth has an impressive academic record with 418 citations across 31 published documents and an h-index of 14, reflecting the strong impact and consistency of his research contributions in infectious diseases and vector biology.


Profiles : ORCID | Scopus

Featured Publications

1. Nolte, K., Agboli, E., Garcia, G. A., Badolo, A., Becker, N., Loc, D. H., Dworrak, T. V., Eguchi, J., Eisenbarth, A., de Freitas, R. M., et al. (2025). Comprehensive mosquito wing image repository for advancing research on geometric morphometric- and AI-based identification.

2. Lubbers, C., Amaral, L.-J., Colebunders, R., Brattig, N., Hadermann, A., & Eisenbarth, A. (2025, October). The last mile in onchocerciasis elimination: Diagnostic challenges.

3. Krüger, A., Balczun, C., Scheid, P. L., Hagen, R. M., & Eisenbarth, A. (2023). Molecular detection of Leishmania (Sauroleishmania) adleri (Trypanosomatida: Trypanosomatidae) in Sergentomyia sp. sand flies (Diptera: Psychodidae) in Mali and Niger.

4. Stoek, F., Barry, Y., Ba, A., Schulz, A., Rissmann, M., Wylezich, C., Sadeghi, B., Beyit, A. D., Eisenbarth, A., N’diaye, F. B., et al. (2022, April 15). Mosquito survey in Mauritania: Detection of Rift Valley fever virus and dengue virus and the determination of feeding patterns.

5. Ngwasiri, N. N., Brattig, N. W., Ndjonka, D., Liebau, E., Paguem, A., Leusder, D., Kingsley, M. T., Eisenbarth, A., Renz, A., & Daniel, A. M. (2021). Correction to: Galectins from Onchocerca ochengi and O. volvulus and their immune recognition by Wistar rats, Gudali zebu cattle and human hosts.

 

 

Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Researcher | Academic Center for Education, Culture and Research | Iran

Dr. Sanaz Ahmadi Ghezeldasht is a distinguished researcher and molecular biologist at the Molecular Biology Section, Central Laboratory ACECR, Mashhad, Iran, specializing in medical immunology, molecular virology, and infectious diseases. She holds a Ph.D. in Medical Immunology from Mashhad University of Medical Sciences, an M.Sc. in Animal Physiology from Payam-e-Noor University of Isfahan, and a B.Sc. in Biology from Ferdowsi University of Mashhad. Dr. Ghezeldasht has served as the Supervisor of the Molecular Biology Center at Jahad Daneshgahi Mashhad, contributing to several national and international research projects focused on HTLV-1 pathogenesis, viral immunology, and host-virus interactions. Her prolific research portfolio encompasses numerous peer-reviewed publications in high-impact journals such as Reviews in Medical Virology, Journal of NeuroVirology, and Applied Biochemistry and Biotechnology, highlighting novel insights into viral oncogenesis, molecular diagnostics, and therapeutic development. A dedicated academic leader, she has organized and contributed to multiple scientific congresses and health monitoring initiatives. Dr. Ghezeldasht’s expertise extends to genetic engineering, bioinformatics, PCR technologies, and cell culture, complemented by certifications in English proficiency and advanced computer literacy. She is an active member of the HTLV-I Foundation and the Research Center for HIV/AIDS, HTLV, and Viral Hepatitis at ACECR, reflecting her enduring commitment to advancing molecular medicine and public health. Her scholarly impact is reflected by 409 citations across 26 publications with an h-index of 10.

Profiles: Scopus | ORCID

Featured Publication

1. Shafaei, A., Talebi, K., Zarean, M., Mosavat, A., Khajedaluee, A. R., Afzalaghaee, M., Shamsian, S. A. A., & Ghezeldasht, S. A. (2025). Intestinal parasitic infections, eosinophilia, and Th1/Th2 immune profiles in haemodialysis patients. Parasite Immunology.

2. Rahimzada, M., Nahavandi, M., Saffari, M., Shafaei, A., Mosavat, A., Ghezeldasht, S. A., Ariaee, N., Valizadeh, N., Rahimi, H., Rezaee, S. A., et al. (2023). Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL). Molecular Biology Reports, 50(9).

3. Yousefpoor, N., Mahdavian, M., Pourbagher, Z., Ghezeldasht, S. A., Mosavat, A., Ziaee, M., Bahreini, M., Soleimanpour, S., Sharifmoghadam, M. R., Valizadeh, N., et al. (2023). Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region. Microbial Pathogenesis, 180, 106170.

4. Ghezeldasht, S. A., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023). Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. Journal of NeuroVirology, 29(4), 567–578.

Lata Deso Abo | Development of New Vaccines | Best Researcher Award

Published on by Infectious

Mr. Lata Deso Abo | Development of New Vaccines | Best Researcher Award

Lecturer and Researcher | Haramaya University, Haramaya Institute of Technology | Ethiopia

Lata Deso Abo is a Lecturer and Researcher in the Department of Chemical Engineering at Haramaya Institute of Technology, Haramaya University, Ethiopia. He earned his Bachelor of Science degree in Chemical Engineering/Process Engineering from Haramaya University in 2017, followed by a Master of Science in Chemical Engineering with a specialization in Bioenergy Engineering from Addis Ababa Science and Technology University in 2021. His research focuses on sustainable technologies, bioenergy, waste valorization, green innovations, and advanced water treatment, with a particular emphasis on bioethanol production, biomass utilization, and the mitigation of industrial fouling in heat transfer systems. Lata has published extensively in reputable journals including Thermal Science Engineering Progress, Environmental Quality Management, Fuel, Chemosphere, and Results in Engineering, contributing studies on heat exchanger fouling, bioethanol optimization through artificial neural networks, biowaste valorization, and the development of eco-friendly biopesticides. His work has also been presented at international conferences such as EPACT-2022 and the AIP Conference Proceedings. In recognition of his scholarly contributions, he has received multiple awards and certificates for teaching performance, research excellence, and editorial reviewing roles in journals like Results in Engineering, Biomass and Bioenergy, and Journal of Environmental Management. Proficient in English and Amharic, and skilled in computational and chemical engineering tools including Aspen Plus, SuperPro Designer, MATLAB, CHEMCAD, and R programming, Lata Deso Abo combines research, teaching, and innovation to advance chemical engineering knowledge and sustainable solutions, making him a distinguished contributor to both academia and applied engineering research. He has 38 citations from 2 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Chozhavendhan, S., Karthigadevi, G., Bharathiraja, B., Kumar, R. P., Abo, L. D., … (2023). Current and prognostic overview on the strategic exploitation of anaerobic digestion and digestate.

2. Jayakumar, M., Hamda, A. S., Abo, L. D., Daba, B. J., Prabhu, S. V., Rangaraju, M., … (2023). Comprehensive review on lignocellulosic biomass derived biochar production, characterization, utilization and applications.

3. Jayakumar, M., Gebeyehu, K. B., Abo, L. D., Tadesse, A. W., Vivekanandan, B., … (2023). A comprehensive outlook on topical processing methods for biofuel production and its thermal applications.

4. Areti, H. A., Muleta, M. D., Abo, L. D., Hamda, A. S., Adugna, A. A., Edae, I. T., Daba, B. J., … (2024). Innovative uses of agricultural by-products in the food and beverage sector.

5. Gari, M. T., Asfaw, B. T., Arumugasamy, S. K., Abo, L. D., … (Year). Natural resources-based activated carbon synthesis.

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

💼Professional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

📚Academic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

📚Teaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum

Dr. Xiaotian Xu | Global Health | Best Researcher Award

Published on by Infectious

Dr. Xiaotian Xu | Global Health | Best Researcher Award

Guilin Medical University | China.

Author Profile

Scopus

🎓Education

Assoc. Prof. Dr. Xiaotian Xu obtained his Ph.D. in Traditional Chinese Medicine from China Pharmaceutical University in 2017, building on his strong foundation with a B.Sc. in Traditional Chinese Medicine from the same institution in 2012. His academic journey has been dedicated to exploring the therapeutic potential of traditional medicine through modern scientific approaches.

💼Professional Experience

Assoc. Prof. Dr. Xiaotian Xu has been serving as an Associate Professor at the School of Pharmacy, Guilin Medical University since 2021, where he focuses on research and education in pharmaceutical sciences. Prior to this, he worked as a Lecturer at the same institution from 2017 to 2021, contributing to academic development and advancing research in traditional medicine and pharmacology.

📚Academic Contributions

Dr. Xu has published multiple high-impact research articles in Journal of Functional Foods, European Journal of Pharmaceutical Sciences, and Cell Death & Disease, focusing on anti-inflammatory compounds and cancer treatment.

🧑‍🔬Technical Skills 

Dr. Xiaotian Xu possesses extensive expertise in natural product extraction and analysis, utilizing advanced techniques to isolate bioactive compounds. His proficiency in molecular pharmacology and cell culture & bioassays enables him to investigate drug mechanisms at the cellular level. Additionally, he specializes in animal disease models for evaluating therapeutic efficacy and applies data analysis & bioinformatics to interpret complex biological data, driving innovative research in pharmaceutical sciences.

📚Teaching Experience

 Assoc. Prof. Dr. Xiaotian Xu is actively involved in teaching Pharmacology of Traditional Chinese Medicine, where he bridges classical knowledge with modern scientific principles. He also lectures on Drug Discovery and Development, guiding students through the processes of identifying and formulating new therapeutic agents. Additionally, he teaches Advanced Research Methods, equipping students with essential skills in experimental design, data analysis, and scientific writing to enhance their research capabilities.

🏆Awards and Honors

NSFC Grant Recipient (2024) for research on durian shell polysaccharides in inflammatory bowel disease

Chinese Patent Holder (2021) for a novel extraction method of p-hydroxybenzaldehyde

🔬Research Interests

Natural compounds in inflammatory disease treatment

Cancer stem cell suppression & ferroptosis

Pharmacological mechanisms of traditional medicine

📑Notable Publications 

“Deep learning-based discovery of compounds for blood pressure lowering effects”

Authors: Li, R.; Wu, T.; Xu, X.; Duan, X.; Wang, Y.
Year: 2025
Journal: Scientific Reports

“p-Hydroxy benzaldehyde, a phenolic compound from Nostoc commune, ameliorates DSS-induced colitis against oxidative stress via the Nrf2/HO-1/NQO-1/NF-κB/AP-1 pathway”

Authors: Liu, M.; Guan, G.; Wang, Y.; Duan, X.; Xu, X.
Year: 2024
Journal: Phytomedicine

“Passion fruit peel fermentation extract and its active component kaempferol alleviate constipation and hemorrhoids in mice by downregulating ESR1 and PI3K/Akt pathways”

Authors: Xu, X.; Li, X.; Wei, X.; Duan, X.; Wang, Y.
Year: 2024
Journal: Journal of Functional Foods

“Characteristics and Influence Factors of Pb(II) Adsorption by Graphene Oxide-Montmorillonite Composite”

Authors: Zhifang, Z.; Xiaotian, X.; Dongxia, L.; Jinlin, C.; Jiyi, Z.
Year: 2024
Journal: Chemistry and Biodiversity

“p-Hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway”

Authors: Liu, M.; Wang, Y.; Xu, X.; Zhu, Y.; Duan, X.
Year: 2024
Journal: Frontiers in Pharmacology